Clinical Trial Update: Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial is recruiting to evaluate vadadustat for treating nonintubated acute respiratory distress syndrome due to pathogen-associated lung injury acros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• Vadadustat (vadadustat)

Snippet

Sponsor: Bentley J. Bobrow | Conditions: Nonintubated Acute Respiratory Distress Syndrome (ARDS), Pathogen-associated Lung Injury | Phase 2, Phase 3 | Status: RECRUITING